Report cover image

Growth Opportunities in the Oral Solid Dosage Formulation Industry

Publisher Frost & Sullivan
Published Apr 08, 2024
SKU # MC18709581

Description

Growth Opportunities in the Oral Solid Dosage Formulation Industry


Personalized Medicine and Drug Delivery Technologies Enhance Future Growth Potential

This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It identifies the most prevalent and emerging business models supporting industry stakeholders in enhancing their competitiveness and service offerings. Discussions on key industry drivers and restraints, partnerships, investment and consolidation activities, disruptive technologies, recent excipient advancements, and present and future trends shed light on the industry’s growth potential. Industry use cases will provide brief insights into game-changing participants working toward developing disruptive technologies and patient-centric drugs. The analysis will also help uncover growth opportunities based on megatrends and business models, clinical needs, use cases, market access strategies, and technology trends.

RESEARCH HIGHLIGHTS:

Impact of strategic imperatives on the industry
Growth drivers and restraints
Oral solid dosage based on API release profile
R&D pipeline and product innovations
Small molecule oral dosage market overview
Small molecule oral solid dosage formulation by therapy area
Innovations in extended-release dosage forms
Industry trends and emerging technologies
Supply chain resilience strategies – focus areas
Investment trends – Expansion and capability-building initiatives
Consolidation trends – mergers & acquisitions
company benchmarking
oral drug delivery solutions & services
Growth opportunities

Table of Contents

Transformation Impacting the Oral Solid Dosage Formulation Growth Environment
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Oral Solid Dosage Formulation Industry
Ecosystem
Scope of Analysis
Industry Definition and Segmentation
Definition—OSD Based on API Release Profile
Growth Generator
Growth Drivers
Growth Restraints
Growth Environment
R&D Pipeline and Product Innovations
Small Molecule Oral Dosage Formulation Industry Overview
Small Molecule OSD Formulation by Therapy Area
Small Molecule OSD Formulation Therapy Area by Dosage Form
Tablet and Capsule Industry—Innovations and Emerging Trends
Innovations in Extended Release Dosage forms
Industry Trends and Emerging Technologies
Tablet and Capsule Industry—Regional Policies and Regulatory Impact
Regional Policies and Initiatives
Tablet and Capsule Industry—Manufacturing and CDMO Industry Overview
OSD Manufacturing—Production Flow
Vendor Ecosystem
Small Molecule OSD CDMO Industry Revenue
OSD CDMO Industry Overview
Supply Chain Resilience Strategies—Focus Areas
Tablet and Capsule Industry—Investment and Consolidation Trends Impacting Growth Themes
Investment Trends—Expansion and Capability Building
Consolidation Trends—Mergers & Acquisitions
Growth Themes and Business Models
Tablet and Capsule Industry—Company Benchmarking based on Differentiated Technologies and Services
Company Benchmarking—Oral Drug Delivery Solutions and Services
Company Benchmarking Analysis
Companies to Watch
Growth Opportunity Universe
Growth Opportunity 1: Fixed Dose Combination Products for Chronic Diseases
Growth Opportunity 2: Medical Cannabidiol
Growth Opportunity 3: Phase-appropriate Services for Orphan Drugs
Growth Opportunity 4: Additive Manufacturing for Personalized Medicine
Best Practices Recognition
Best Practices Recognition
Frost Radar
Frost Radar
Next Steps
Benefits and Impacts of Growth Opportunities
Next Steps
Take the Next Step
List of Exhibits
Legal Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us